NCT00646230 2023-04-07
IV Fenretinide
Children's Hospital Los Angeles
Phase 1 Completed
Clinical Trials
7 trialsNCT00104923 2017-07-19
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
California Cancer Consortium
Phase 1 Completed
NCT00003250 2014-04-11
Fenretinide in Treating Patients With Solid Tumors
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00387504 2013-09-12
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
California Cancer Consortium
Phase 1 Completed
NCT00003191 2013-02-07
Fenretinide in Treating Children With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005819 2010-06-11
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00001378 2008-03-04
A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed